The Company for Life's Journey
Latest News

01.03.2011

Ian McNiece Joins Board.

Website Update

PROTEONOMIX, INC. a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, is pleased to provide an update on the Company's addition to its Board of Directors. Proteonomix, Inc. is pleased to announce that Ian McNiece has been appointed to the Proteonomix Board of Directors effective today.

Read Full Story >

12.13.2010

Favorable Technology Similarities.

New Subsidiary XGen Medical LLC.

PROTEONOMIX, INC. (OTCBB: PROT) notes the favorable similarity between technology involved in the Cephalon, Inc. (CEPH) transaction with Australian company Mesoblast Limited.

Read Full Story >

12.02.2010

Website Update

International Strategic Joint Ventures

PROTEONOMIX, INC. announced today that it has updated its corporate website (http://www.proteonomix.com) to reflect the dynamic growth and investment opportunity that exists today.

Read Full Story >
Media Inquiries
Order a Brochure
Company
Get Involved
Inside Proteonomix
Contact

Home

What We Do

Who We Are

Affiliates

Cord Blood Bank

Investors

Partners

Careers

Order Brochure

News + Events

Technology

Health Care Pratitioners

Media Inquiries

Proteoderm, Inc.

187 Mill Lane
Mountainside, NJ 07092-2909

p. 973.544.6116
e. info@proteonomix.com

© Copyright 2011 Proteonomix, Inc. Site Map